Skip to main content
Fig. 9 | BMC Medical Genomics

Fig. 9

From: A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs

Fig. 9

Correlation between common TKIs and the immune-related lncRNA signature. (a–h) The high-risk samples were positively related to the IC50 of gefitinib (a), sunitinib (b), and tipifarnib (c) but negatively related to axitinib (e), AMG-706 (f), and pazopanib (g). Lenvatinib (d) and sorafenib (h) had no relationship with the signature. (< 0.001 = ***, < 0.01 = **, and < 0.05 = *)

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us